Kaper, J.B., Nataro, J.P., Mobley, H.L.: Pathogenic Escherichia coli. Nature reviews. 2, 123–140 (2004). https://doi.org/10.1038/nrmicro818
CAS
Article
PubMed
Google Scholar
Russo, T.A., Johnson, J.R.: Medical and economic impact of extraintestinal infections due to Escherichia coli. focus on an increasingly important endemic problem. Microbes and infection / Institut Pasteur. 5, 449–456 (2003)
Article
Google Scholar
Rogers, B.A., Sidjabat, H.E., Paterson, D.L.: Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66, 1–14 (2011). https://doi.org/10.1093/jac/dkq415
CAS
Article
PubMed
Google Scholar
Coque, T.M., Novais, A., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., Nordmann, P.: Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14, 195–200 (2008). https://doi.org/10.3201/eid1402.070350
CAS
Article
PubMed
PubMed Central
Google Scholar
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M.P., Caniça, M.M., Park, Y.-J., Lavigne, J.-P., Pitout, J., Johnson, J.R.: Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. (2008). https://doi.org/10.1093/jac/dkm464
Johnson, J.R., Johnston, B., Clabots, C., Kuskowski, M.A., Castanheira, M.: Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. (2010). https://doi.org/10.1086/653932
Clermont, O., Lavollay, M., Vimont, S., Deschamps, C., Forestier, C., Branger, C., Denamur, E., Arlet, G.: The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61, 1024–1028 (2008). https://doi.org/10.1093/jac/dkn084
CAS
Article
PubMed
Google Scholar
Szijártó, V., Lukasiewicz, J., Gozdziewicz, T.K., Magyarics, Z., Nagy, E., Nagy, G.: Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4. Clin. Vaccine Immunol. 21, 930–939 (2014). https://doi.org/10.1128/CVI.00685-13
Article
PubMed
PubMed Central
Google Scholar
Stenutz, R., Weintraub, A., Widmalm, G.: The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol. Rev. 30, 382–403 (2006)
CAS
Article
Google Scholar
Whitfield, C., Trent, M.S.: Biosynthesis and export of bacterial lipopolysaccharides*. Annu. Rev. Biochem. 83, 99–128 (2014). https://doi.org/10.1146/annurev-biochem-060713-035600
CAS
Article
PubMed
Google Scholar
Miajlovic, H., Smith, S.G.: Bacterial self-defence: how Escherichia coli evades serum killing. FEMS Microbiol. Lett. 354, 1–9 (2014). https://doi.org/10.1111/1574-6968.12419
CAS
Article
PubMed
Google Scholar
Poolman, J.T., Wacker, M.: Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and Progress in the field. J. Infect. Dis. 213, 6–13 (2015). https://doi.org/10.1093/infdis/jiv429
CAS
Article
PubMed
PubMed Central
Google Scholar
Vella, M., Pace, D.: Glycoconjugate vaccines: an update. Expert. Opin. Biol. Ther. 15, 529–546 (2015). https://doi.org/10.1517/14712598.2015.993375
CAS
Article
PubMed
Google Scholar
Szu, S.C.: Development of vi conjugate - a new generation of typhoid vaccine. Expert Rev Vaccines. 12, 1273–1286 (2013). https://doi.org/10.1586/14760584.2013.845529
CAS
Article
PubMed
Google Scholar
Cross, A., Artenstein, A., Que, J., Fredeking, T., Furer, E., Sadoff, J.C., Cryz Jr., S.J.: Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteers. J. Infect. Dis. 170, 834–840 (1994)
CAS
Article
Google Scholar
Wacker, M., Linton, D., Hitchen, P.G., Nita-Lazar, M., Haslam, S.M., North, S.J., Panico, M., Morris, H.R., Dell, A., Wren, B.W., Aebi, M.: N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science. 298, 1790–1793 (2002)
CAS
Article
Google Scholar
Feldman, M.F., Wacker, M., Hernandez, M., Hitchen, P.G., Marolda, C.L., Kowarik, M., Morris, H.R., Dell, A., Valvano, M.A., Aebi, M.: Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 102, 3016–3021 (2005)
CAS
Article
Google Scholar
Phan, M.-D., Peters, K.M., Sarkar, S., Lukowski, S.W., Allsopp, L.P., Gomes Moriel, D., Achard, Maud E S, Totsika, M., Marshall, V.M., Upton, M., Beatson, S.A., Schembri, M.A.: The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet (2013). https://doi.org/10.1371/journal.pgen.1003834
Ravenscroft, N., Haeuptle, M.A., Kowarik, M., Fernandez, F.S., Carranza, P., Brunner, A., Steffen, M., Wetter, M., Keller, S., Ruch, C., Wacker, M.: Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli. Glycobiology. cwv077 (2016). https://doi.org/10.1093/glycob/cwv077
Wacker, M., Wang, L., Kowarik, M., Dowd, M., Lipowsky, G., Faridmoayer, A., Shields, K., Park, S., Alaimo, C., Kelley, K.A., Braun, M., Quebatte, J., Gambillara, V., Carranza, P., Steffen, M., Lee, J.C.: Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli. J. Infect. Dis. 209, 1551–1561 (2014). https://doi.org/10.1093/infdis/jit800
CAS
Article
PubMed
Google Scholar
Ihssen, J., Kowarik, M., Dilettoso, S., Tanner, C., Wacker, M., Thony-Meyer, L.: Production of glycoprotein vaccines in Escherichia coli. Microb. Cell Factories. 9, 61 (2010). https://doi.org/10.1186/1475-2859-9-61
CAS
Article
Google Scholar
Kowarik, M., Wetter, M., Kemmler, S., Häuptle, M., Gambillara, V., Mally, M.: Polysaccharide and uses thereof Patent US10441647B2
Lee, D.J., Bingle, L.E., Heurlier, K., Pallen, M.J., Penn, C.W., Busby, S.J., Hobman, J.L.: Gene doctoring. a method for recombineering in laboratory and pathogenic Escherichia coli strains. BMC Microbiol. 9, 252 (2009)
Article
Google Scholar
Wacker, M., Kowarik, M., Fernandez, F.: Methods of host cell modification Patent EP3055416B1
Datsenko, K.A., Wanner, B.L.: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97, 6640–6645 (2000)
CAS
Article
Google Scholar
Apicella, M.A.: Isolation and characterization of lipopolysaccharides. Methods in molecular biology (Clifton, N.J 431, 3–13 (2008)
Kämpf, M.M., Braun, M., Sirena, D., Ihssen, J., Thöny-Meyer, L., Ren, Q.: In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation. Microb. Cell Factories. 14, 12 (2015). https://doi.org/10.1186/s12934-015-0195-7
CAS
Article
Google Scholar
van den Dobbelsteen, Germie P.J.M., Faé, K.C., Serroyen, J., van den Nieuwenhof, Ingrid M., Braun, M., Haeuptle, M.A., Sirena, D., Schneider, J., Alaimo, C., Lipowsky, G., Gambillara-Fonck, V., Wacker, M., Poolman, J.T.: Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models. Vaccine (2016). https://doi.org/10.1016/j.vaccine.2016.06.067
Wetter, M., Kowarik, M., Steffen, M., Carranza, P., Corradin, G., Wacker, M.: Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component. Glycoconj. J. 30, 511–522 (2013). https://doi.org/10.1007/s10719-012-9451-9
CAS
Article
PubMed
Google Scholar
Kim, J.S., Laskowich, E.R., Arumugham, R.G., Kaiser, R.E., MacMichael, G.J.: Determination of saccharide content in pneumococcal polysaccharides and conjugate vaccines by GC-MSD. Anal. Biochem. 347, 262–274 (2005). https://doi.org/10.1016/j.ab.2005.09.022
CAS
Article
PubMed
Google Scholar
Beczała, A., Duda, K.A., Skurnik, M., Holst, O.: The structure of the O-specific polysaccharide of the lipopolysaccharide from Yersinia enterocolitica serotype O:50 strain 3229. Carbohydr. Res. 359, 97–101 (2012). https://doi.org/10.1016/j.carres.2012.06.002
CAS
Article
PubMed
Google Scholar
Gerwig, G.J., Kamerling, J.P., Vliegenthart, J.F.G.: Determination of the d and l configuration of neutral monosaccharides by high-resolution capillary g.l.c. Carbohydr Res (1978). https://doi.org/10.1016/S0008-6215(00)80881-2
Gerwig, G.J., Kamerling, J.P., Vliegenthart, J.F.: Determination of the absolute configuration of mono-saccharides in complex carbohydrates by capillary G.L.C. Carbohydr. Res. 77, 10–17 (1979)
CAS
Article
Google Scholar
Harris, P.J., Henry, R.J., Blakeney, A.B., Stone, B.A.: An improved procedure for the methylation analysis of oligosaccharides and polysaccharides. Carbohydr. Res. 127, 59–73 (1984)
CAS
Article
Google Scholar
Albersheim, P., Nevins, D.J., English, P.D., Karr, A.: A method for the analysis of sugars in plant cell-wall polysaccharides by gas-liquid chromatography. Carbohydr. Res. 5, 340–345 (1967). https://doi.org/10.1016/S0008-6215(00)80510-8
CAS
Article
Google Scholar
Sweet, D.P., Shapiro, R.H., Albersheim, P.: Quantitative analysis by various g.l.c. response-factor theories for partially methylated and partially ethylated alditol acetates. Carbohydr Res (1975). https://doi.org/10.1016/S0008-6215(00)82604-X
Gottlieb, H.E., Kotlyar, V., Nudelman, A.: NMR chemical shifts of common laboratory solvents as trace impurities. J. Organic Chem. 62, 7512–7515 (1997)
CAS
Article
Google Scholar
Kenne, L., Lindberg, B., Madden, J.K., Lindberg, A.A., Gemski, P.: Structural studies of the Escherichia coli O-antigen 25. Carbohydr. Res. 122, 249–256 (1983)
CAS
Article
Google Scholar
Lundborg, C., Westerlund, A., Bjorklund, U., Biber, B., Hansson, E.: Ifenprodil restores GDNF-evoked Ca(2+) signalling and Na(+)/K(+) -ATPase expression in inflammation-pretreated astrocytes. J. Neurochem. 119, 686–696 (2011). https://doi.org/10.1111/j.1471-4159.2011.07465.x
CAS
Article
PubMed
Google Scholar
Stevenson, G., Neal, B., Liu, D., Hobbs, M., Packer, N.H., Batley, M., Redmond, J.W., Lindquist, L., Reeves, P.: Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster. J. Bacteriol. 176, 4144–4156 (1994)
CAS
Article
Google Scholar
K.R. Talaat, C. Alaimo, A.L. Bourgeois, R.W. Kaminski, A. Dreyer, C.K. Porter, S. Chakraborty, K. A. Clarkson, J. Brubaker, D. Elwood, R. Frölich, B. DeNearing, H. Weerts, B. Feijoo, D. Sack, M.S. Riddle, P. Martin, V. Gambillara Fonck: Flexyn2a, a candidate bioconjugate vaccine against shigella flexneri 2a induces protective immune response in a controlled human infection model. Vaccines for enteric diseases, Albufeira, (2017)
Hatz, C., Bally, B., Rohrer, S., Steffen, R., Kramme, S., Siegrist, C.-A., Wacker, M., Alaimo, C., Fonck, V.G.: Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: a single blind, partially randomized phase I study. Vaccine. 33, 4594–4601 (2015). https://doi.org/10.1016/j.vaccine.2015.06.102
CAS
Article
PubMed
Google Scholar
Huttner, A., Hatz, C., van den Dobbelsteen, Germie, Abbanat, D., Hornacek, A., Frölich, R., Dreyer, A.M., Martin, P., Davies, T., Fae, K., van den Nieuwenhof, Ingrid, Thoelen, S., de Vallière, S., Kuhn, A., Bernasconi, E., Viereck, V., Kavvadias, T., Kling, K., Ryu, G., Hülder, T., Gröger, S., Scheiner, D., Alaimo, C., Harbarth, S., Poolman, J., Fonck, V.G.: Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial. The Lancet Infectious Diseases (2017). https://doi.org/10.1016/S1473-3099(17)30108-1
Inoue, M., Ogawa, T., Tamura, H., Hagiwara, Y., Saito, Y., Abbanat, D., van den Dobbelsteen, Germie, Hermans, P., Thoelen, S., Poolman, J., de Palacios, Patricia Ibarra: Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive Extraintestinal pathogenic Escherichia coli disease: a phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants. Hum Vaccin Immunother (2018). https://doi.org/10.1080/21645515.2018.1474316
Frenck, R.W., Ervin, J., Chu, L., Abbanat, D., Spiessens, B., Go, O., Haazen, W., van den Dobbelsteen, Germie, Poolman, J., Thoelen, S., Ibarra de Palacios, P.: Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial. The Lancet Infectious Diseases (2019). https://doi.org/10.1016/S1473-3099(18)30803-X
van den Dobbelsteen, G.P., van Dijken, H.H., Pillai, S., van Alphen, L.: Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs. Vaccine. 25, 2491–2496 (2007). https://doi.org/10.1016/j.vaccine.2006.09.025
CAS
Article
PubMed
Google Scholar